100% renewable electricity across all four manufacturing plants Galderma achieved 100% renewable electricity across all four manufacturing sites in 2023 (up from 57% in 2022) and maintained this in 2024. The company commits to maintaining 100% renewable electricity in its manufacturing plants as part of its Scope 1 & 2 carbon neutrality ambition by 2030.
▾ expand
IPO on SIX Swiss Exchange Galderma debuted as a publicly-listed company (GALD) on the SIX Swiss Exchange on March 22, 2024 — the largest IPO in Switzerland since 2017 and one of the largest healthcare IPOs ever.
▾ expand
Scope 1 & 2 carbon neutrality in manufacturing by 2030 Galderma set target to achieve Scope 1 & 2 carbon neutrality across its four manufacturing plants by 2030. Includes phasing capex to replace carbon-intensive equipment and maintaining 100% renewable electricity.
▾ expand
Water and waste intensity reduction 20% by 2030 Reduce water withdrawal intensity by 20% from a 2022 baseline and reduce waste intensity by 20% from a 2022 baseline across manufacturing plants by 2030.
▾ expand
50% of affiliates Great Place to Work certified In 2024, 50% of Galderma affiliates received Great Place to Work recognitions, including Galderma U.S. with workforce of ~1,200 people.
▾ expand
ISO 45001 across all manufacturing plants All four Galderma manufacturing plants obtained and maintain ISO 45001, ISO 14001 and OHSAS 18001 certifications.
▾ expand
Primary: Water withdrawal intensity reduction Galderma is committed to enhancing water efficiency in manufacturing. Actions taken include reducing purge volumes and optimizing cooling processes. In 2024, water meters and sensors were installed across manufacturing plants and water withdrawal intensity decreased by more than 10% year-over-year. Target: 20% reduction by 2030 vs 2022 baseline.
▾ expand
Dependent: Sustainable packaging initiative In 2024, Galderma launched a Sustainable Packaging Initiative to identify all potential sustainable packaging solutions across the Dermatological Skincare portfolio, prioritising by impact/feasibility and considering resource availability such as post-consumer recycled (PCR) plastic. A multi-disciplinary project team across Operations, Procurement, R&D, Commercial and ESG was assembled.
▾ expand
100% renewable electricity across all 4 manufacturing plants Galderma achieved 100% renewable electricity across all four manufacturing sites in 2023 and maintained this in 2024. To achieve Scope 1 & 2 carbon neutrality in its manufacturing plants by 2030, Galderma developed site-specific plans that include phasing capital expenditure to replace carbon-intensive equipment (e.g., gas boilers) and maintaining 100% renewable electricity. The plan also comprises acquisition of high-quality carbon credits to compensate for residual emissions.
▾ expand
20% waste intensity reduction target by 2030 Galderma aims to reduce waste intensity by 20% from a 2022 baseline across its manufacturing plants by 2030.
▾ expand
see 18 more events →